The homogeneity between these observational studies supports the interest in THC:CBD oromucosal spray for management of MS spasticity in daily practice.
Link: THC:CBD In Daily Practice: Available Data From UK, Germany And Spain
Year: 2016
Likely probability of the efficacy of cannabis for treatment of Multiple Sclerosis (MS) according to the results found in this study.
Sativex (THC:CBD) oromucosal spray